LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .6. PHARMACOKINETICS OF THEENANTIOMERS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA, URINE AND CEREBROSPINAL-FLUID

Citation
Gp. Kaijser et al., LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .6. PHARMACOKINETICS OF THEENANTIOMERS OF IFOSFAMIDE, 2-DECHLOROETHYLIFOSFAMIDE AND 3-DECHLOROETHYLIFOSFAMIDE IN PLASMA, URINE AND CEREBROSPINAL-FLUID, Journal of drug development and clinical practice, 7(4), 1996, pp. 319-326
Citations number
23
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
13579215
Volume
7
Issue
4
Year of publication
1996
Pages
319 - 326
Database
ISI
SICI code
1357-9215(1996)7:4<319:LTIDD.>2.0.ZU;2-L
Abstract
A chiral gas chromatographic method was used to determine the concentr ation and enantiomeric ratios of ifosfamide, 2- and 3-dechloroethylifo sfamide in plasma, urine and cerebrospinal fluid samples from 10 patie nts treated with ifosfamide. It appeared that some metabolic preferenc e exists for S-ifosfamide. However, this preference does not always le ad to a higher excretion of the metabolite isomers, S-2- and R-3-dechl oroethylifosfamide originating from S-ifosfamide. The differences in s tereospecific metabolism could not be correlated with age, sex, durati on of the infusion of ifosfamide dose.